Teladoc completed the acquisition and merger with Livongo in a $18.5bn deal.

Teladoc Health, a multinational telemedicine and virtual healthcare company, completed the acquisition and merger with Livongo Health, a diabetes prevention and behavioural healthcare services provider, in a $18.5bn deal. Under the terms of the agreement, which has been unanimously approved by the Board of Directors of each company, each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of $11.33 for each Livongo share. Upon completion of the merger, existing Teladoc Health shareholders will own approximately 58% and existing Livongo shareholders will own approximately 42% of the combined company. “This merger firmly establishes Teladoc Health at the forefront of the next-generation of healthcare. Livongo is a world-class innovator we deeply admire and has demonstrated success improving the lives of people living with chronic conditions. Together, we will further transform the healthcare experience from preventive care to the most complex cases, bringing ‘whole person’ health to consumers and greater value to our clients and shareholders as a result,” Jason Gorevic, Teladoc Health CEO.